DynPort Vaccine Company LLC   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Frederick MD United States (1997)
Status: Acquired by General Dynamics (2018)

Organization Overview

First Clinical Trial
2002
NCT00042094
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

DynPort Vaccine Company, a CSC Company